A Federal Protein Research Push Targets Disease Before Clumps Form

The Advanced Research Projects Agency for Health announced research teams on October 9 for a program aimed at identifying and redirecting protein dysfunction before harmful clumps damage cells. Called BIOGAMI, the effort carries an agency commitment of up to $152 million over four years. Awards depend on teams meeting research milestones, according to the federal announcement. That conditional structure makes this a research investment, not a declaration that preventive treatments have been developed.

The program concentrates on intrinsically disordered proteins and regions: flexible molecular components whose behavior can change with biological circumstances. ARPA-H describes aging, inherited risk and environmental factors as influences that can push these regions toward abnormal folding or aggregation. Its proposed intervention point is early in that process, before the accumulation associated with damage in vulnerable tissues, especially the brain.

A problem of context as well as sequence

The agency’s description goes beyond asking what shape follows from a protein’s sequence. Several funded projects explicitly examine context, including metabolites, membranes, cellular stress and interactions with other molecules. This emphasis is central to the program’s logic: a useful model must capture conditions that shift protein behavior, rather than simply attach one fixed shape to a sequence. Whether the teams can build sufficiently predictive models remains the research question.

Johns Hopkins University leads Dynamic Ensemble-to-Rescue, or DETR, with Xiaobo Mao as principal investigator. The award record lists a September 30 start date and funding of up to $52.1 million. Its goals include predicting disordered-region behavior, identifying temporary disease-relevant shapes and designing interventions that prevent pathological configurations. The initial disease applications include Parkinson’s and related disorders involving alpha-synuclein, as well as Ewing sarcoma.

The Hopkins project plans to design protein and cyclic peptide binders, according to ARPA-H. Those are proposed tools for influencing molecular behavior, not treatments shown by this announcement to work in patients. The distinction between identifying a potentially important shape and safely changing a disease process is therefore essential to reading the award: diagnostic and therapeutic applications are the intended destination, not a reported outcome.

Different teams test different parts of the hypothesis

A Massachusetts Institute of Technology team will build computational models that incorporate metabolites and lipid interfaces as central variables. A University of California, Berkeley team will assemble a broad dataset of disordered-region sequences and visualize protein behavior in living cells. These projects address complementary gaps: the circumstances surrounding a protein and the breadth of examples available to train or evaluate models of its behavior.

Other teams connect that foundational work to particular disease mechanisms. The Buck Institute for Research on Aging and Georgetown University will map how sequence and biological context influence proteins, including aggregation-prone disease proteins. University of California, San Francisco researchers will investigate the hypothesis that stress-regulated disordered regions enter mitochondria and contribute to neurodegenerative disease. The agency presents that mitochondrial mechanism as a hypothesis to explore, not a settled conclusion.

A University of North Carolina, Chapel Hill team will combine computational and experimental work to map context-dependent protein behavior, then design indicators and modulators of early aggregation before advancing candidates into preclinical studies. Across the program, the announced sequence is clear: build tools, identify useful signals and interventions, and test candidates. The consequential question is whether this approach can turn early molecular changes into reliable opportunities for intervention; the funding announcement itself cannot answer it.